Search
Medical practices, dental practices and other health care entities must again comply with the federal Corporate Transparency Act (“CTA”). The deadline for compliance is March 21, 2025. What You Need to Know: The Corporate Transparency Act filing deadline is now March 21, 2025. Medical practices and...
The CTA madness continues. On December 23, 2024, the U.S. Court of Appeals for the Fifth Circuit (the "Fifth Circuit"), in the case of Texas Top Cop Shop v. Garland ("Texas Top Cop Shop"), stayed the enforcement of an injunction issued by the U.S. District Court for the Eastern District of Texas...
On December 23, 2024, the U.S. Court of Appeals for the Fifth Circuit (“Fifth Circuit”) granted the U.S. Government’s motion to stay the nationwide preliminary injunction issued by U.S. District Court for the Eastern District of Texas (“District Court”) on December 3, 2024, which temporarily halted...
On April 23, 2024, the Federal Trade Commission (FTC) issued its proposed final rule (the “Rule”) banning the use of future noncompete agreements for all workers, including senior executives, 89 FR 38342. Noncompete agreements have long been a valuable tool in a company’s toolbox to mitigate the...
The decision of the Federal District Court for the Northern District of Alabama in the case of National Small Business United v. Yellen , announced on Friday, March 1, 2024, has created uncertainty for both reporting companies and their attorneys under the Corporate Transparency Act (“CTA”). What...
For all “reporting companies” created or registered on or after January 1, 2024, information concerning the “beneficial owners” of the reporting company must be reported to the Financial Crimes Enforcement Network (“FinCEN”) along with information concerning “company applicants.” As a result, both...
A 2023 update on corporate litigation in the Delaware Court of Chancery, as well as an update on the annual amendments made to the General Corporation Law of the State of Delaware and alternative entity acts, which were all effective as of August 1, 2023. The material statutory amendments discussed...
“Company applicants” — the term may sound vague, but the identities of “company applicants” of reporting companies are just as important under the new federal Corporate Transparency Act (the “CTA”) as the identities of the beneficial owners of those companies. What You Need to Know: The era of...
When allegations of research fraud or misconduct come to light, the stakes for companies and research institutions could not be higher. Actions such as fabrication of scientific data, manipulation of research materials, and plagiarism can result in damaged reputations, loss of federal funding, and...

Edward (Ted) Behm brings more than 20 years of experience as an intellectual property attorney to his work assisting clients with patent preparation and prosecution and IP litigation. His patent preparation and prosecution work includes both domestic and foreign patents, trademarks and copyrights...
Counsel on Commercial Arrangements, Business Operations and Regulatory Matters Regardless of size or structure, health care providers, payors, entrepreneurs and businesses must navigate a complex maze of federal and state laws and regulations to remain economically competitive. Health care...
Responsive Service and Real-World Guidance Attorneys in Saul Ewing's Financial Services Practice advise and represent local, community and regional banks; credit unions; and other private and public finance entities in a wide range of transactional and business matters. We provide practical legal...
Strategically Positioned to Navigate Distress, Drive Opportunity Saul Ewing’s Distressed Transactions practice provides comprehensive, interdisciplinary solutions for clients such as businesses, investors or stakeholders navigating market distress and economic uncertainty. Our team performs due...

Bunyad Bhatti focuses her practice on helping health care facilities and health care technology companies navigate issues involving regulatory compliance and corporate governance. Bunyad provides advice on an array of industry-specific policies and procedures, including HIPAA, and drafts privacy...

A life sciences patent attorney with a Ph.D. in virology and cell and molecular biology, Kathryn Doyle represents universities and companies throughout the United States in identifying, protecting and enforcing their intellectual property in the areas of biotechnology, pharmaceuticals, agriculture...

David Berk counsels families and their businesses, entrepreneurs and start-up companies in taxation, structuring transactions, contract negotiations and governance issues. David also advises clients on corporate succession planning, trust and estate planning, insurance and retirement planning and...

Marshall Paul focuses his practice on counseling businesses, nonprofit organizations, health care concerns and professionals with respect to limited liability company matters, general corporate matters, joint ventures, acquisitions and sales, fiduciary duty issues and financings. His clients include...

Eric Orlinsky concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity securities, mergers and acquisitions, purchases and sales of businesses. Eric also provides general...